The Color of COVID: Will Vaccine Trials Reflect America’s Diversity?
Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they’ve historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
http://dlvr.it/RcRM52
http://dlvr.it/RcRM52
Comments
Post a Comment